Aryl derivatives for treating TRPM3 mediated disorders
PH12023551444B1Active Publication Date: 2026-08-12KATHOLIEKE UNIV LEUVEN
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12023551444
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-05-24
- Publication Date
- 2026-08-12
- Estimated Expiration
- 2043-05-24
Abstract
The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.
Need to check novelty before this filing date? Find Prior Art